Twomey Christopher J's Form 4 filing
Tandem Diabetes Care Inc (TNDM) · filed Sep 9, 2021
- Accession no.
- 0001438133-21-000161
- Filed
- Sep 9, 2021
- Trade date
- Sep 7-8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $37.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Twomey Christopher JCIK 0001238935 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Common Stock | SSaleDisposed | −304 | $123.00 | −$37,392 | 7,532 | Indirect | |
| Sep 8, 2021 | Common Stock | GGiftDisposed | −2,500 | $129.09F4 | −$322,725 | 5,032 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.
Referenced by the price of 1 transaction in Table I.